Numerous tools have been created in the last years, how do these early-stage financing vehicles work? On which bases do they ground funds allocation? What are the expectations of the limited partners? Who are the players involved in such investment tools, and what do they await from their involvement in such early-stage funding and investment tools?

Avishai Levy - Agbiopro
Mark Slack - Evotec
Youness Karrout - University of Lille
Iain Thomas - Cambridge Enterprise

Continue your tour